Olympus Completes Acquisition of Taewoong Medical

Olympus today announced the closing of its acquisition of Taewoong Medical, which manufactures gastrointestinal (GI) metallic stents, along with additional product offerings. The acquisition, which cost approximately $370 million, included a $255.5 million lump sum at closing and an additional $114.5 million upon completion of future milestones.